TET2 deficiency promotes MDS-associated leukemogenesis.
- Published in:
- 2022
- By:
- Publication type:
- Letter
Works matching IS 20445385 AND DT 2022 AND VI 12 AND IP 10
Results: 4
1
2
Prognostic impact of ASXL1 mutations in chronic phase chronic myeloid leukemia.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 10, p. 1, doi. 10.1038/s41408-022-00742-1
- By:
- Publication type:
- Article
3
Effect of granulocyte colony-stimulating factor on toxicities after CAR T cell therapy for lymphoma and myeloma.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 10, p. 1, doi. 10.1038/s41408-022-00741-2
- By:
- Publication type:
- Article
4
High efficacy of Azacitidine plus HAG in acute myeloid leukemia: an open-label, single-arm, multi-center, phase 2 study.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 10, p. 1, doi. 10.1038/s41408-022-00740-3
- By:
- Publication type:
- Article